Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Sexual-stage surface protein Pfs25 from *Plasmodium falciparum* is an essential molecule expressed after fertilization during sexual reproduction inside mosquitoes. Its unique structure makes it both challenging as a vaccine target but also highly effective: antibodies targeting conformational epitopes on native/recombinant Pfs25 can prevent further parasite development within mosquitoes—thus blocking human-to-mosquito malaria transmission entirely. This has made it one of the most intensively studied targets for next-generation TBVs aiming at global malaria elimination efforts.
Antibody-mediated blockage of parasite development in the mosquito midgut
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sexual-stage Surface Protein Pfs25 (Pfs25).